MedPath

The effect of alpha lipoic acid on pain and expression of genes involved in implantation in infertile women with endometriosis

Phase 2
Conditions
Endometriosis.
Registration Number
IRCT20220817055727N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
30
Inclusion Criteria

Women aged 18-44 years with pain and suspected endometriosis
Do not take hormonal drugs containing estrogen or progesterone for three months
No pregnancy
Absence of genital or breast cancers
No abnormal vaginal bleeding
No breastfeeding for 3 months
Do not use housing during the last week
No surgery in the last 3 months
No liver problems
No strong history of venous thrombosis or embolism
Body mass index 5 / 18-26

Exclusion Criteria

Has a history of any genital cancer in the pelvic area
Hormone therapy for the past 3 months
Suffering from a variety of systemic diseases
History of endometrial destruction by thermal balloon or resectoscope

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intensity of pain. Timepoint: Before and 8 weeks after treatment. Method of measurement: Vas score questionnaire.;The level of expression of genes involved in implantation. Timepoint: Before and 8 weeks after treatment. Method of measurement: pcr-real time device.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath